Female genital prolapse

N14_FEMGENPROL

male reproductive organ cancer: A reproductive organ cancer that is manifested in the male genital system. This includes organs such as the penis and scrotum.

Endpoint definition

FinnGen phenotype data

321302 individuals

diagram downward connector
diagram bullet

Apply sex-specific rule

Sex only females

180574

diagram downward connector

Check conditions None

180574

diagram downward connector
diagram bullet

Filter registries

Hospital Discharge: ICD-10 N81
Hospital discharge: ICD-9 618
Hospital discharge: ICD-8 623
Hospital discharge: excluded ICD-9 6185
Cause of death: ICD-10 N81
Cause of death: ICD-9 618
Cause of death: ICD-8 623
Cause of death: excluded ICD-9 6185

13984

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

13811

diagram downward connector

Check minimum number of events None

13811

diagram downward connector

Include endpoints None

13811

diagram downward connector
N14_FEMGENPROL

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2
Parent code in ICD-10 N80-N98
Name in latin Prolapsus organorum genitalium femininorum

Summary Statistics

Key figures

All Female Male
Number of individuals 13420 13420 -
Unadjusted prevalence (%) 4.35 7.73 -
Mean age at first event (years) 56.79 56.79 -

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.01 0.62 [0.52, 0.73] 5.7e-8 863
15 years 0.00 0.43 [0.36, 0.50] 7.2e-24 415
5 years 0.00 0.57 [0.47, 0.70] 3.6e-8 142
1 year 0.00 0.67 [0.46, 0.98] 3.8e-2 30

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: N14_FEMGENPROL – Female genital prolapse
GWS hits: 13

Survival analyses between endpoints

Plot

before Female genital prolapse
after Female genital prolapse

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Female genital prolapse